Melanoma Institute Australia

ASI Annual Scientific Meeting
2026-11-30 - 2026-12-04 | QT Canberra, 1 London Cct, Canberra, 2601, Australia
The ASI 2026 Local Organising Committee warmly invites you to join us for the 54th Annual Scientific Meeting of the Australian and New Zealand Society for Immunology (ASI), to be held 30 November – 4 December 2026 in Canberra (Ngunnawal Country), Australia’s national capital.
Set in one of the world’s most sustainable and liveable cities, Canberra offers the perfect setting for a week of discovery, connection, and scientific excellence. Our comprehensive program will spotlight the leading immunological research from Australia, New Zealand and around the world. The program will include a wide range of topics covering cutting-edge fundamental, translational, and clinical immunology—from infection, inflammation, and autoimmunity to tumour immunology, and immunometabolism.
Our meeting venue, QT Canberra, provides an intimate environment designed to support vibrant discussion and collaboration. Set close to the city centre, on the shores of Lake Burley Griffin, you will be within easy reach to a thriving food and wine scene, national museums and galleries and scenic outdoor spaces providing every opportunity to immerse yourself in the best Canberra has to offer.
We look forward to welcoming you to ASI 2026 in Canberra—a meeting that promises rich scientific exchange, renewed connections, and an engaging celebration of our immunology community.

Location: QT Canberra, Canberra, Australia
Key Dates:
Abstract Submission Deadline: mid-late August 2026
Abstract Decision Notification: Sep – Oct 2026
Early Bird Registration Deadline: mid-late August 2026
Standard Registration Deadline: 23 November 2026

FIND OUT MORE

Multi-Omics Conference
2026-12-06 - 2026-12-08 | Brisbane Convention and Exhibition Centre, Cnr Merivale and Glenelg Streets, South Bank, Brisbane, QLD, 4101, Australia
JOIN US IN THE FIGHT TO CURE CANCER!
This meeting brings together a critical mass of national and international leaders in multi-omics, offering:
– Cutting-edge science and real-world datasets
– Platform launches and hands-on technical workshops
– Engagement with leading technology providers
– A collaborative space to shape the future of precision medicine
Whether you’re decoding spatial signatures, refining analytical pipelines, or driving clinical translation, Multi-Omics 2026 is your launchpad. We look forward to welcoming you to Brisbane, where discovery meets translation.
Over three dynamic days, Multi-Omics 2026 will spotlight the latest breakthroughs in:
– Spatial Biology Methods and Applications
– Spatial Medicine
– Computational Biology
– AI-powered Omics Analytics
Sessions will span immuno-oncology, infectious disease, and computational immunology, with a strong emphasis on experimental design, cohort architecture, and translational impact.
Location: Brisbane Convention & Exhibition Centre
Key Dates:
Conference dates: 6-8 December 2026
Regular Registration Deadline: 30 September 2026
Late Registration Deadline: 1 October 2026 onwards
FIND OUT MORE

Cancer Research Institute | IGNITE Award
2027-01-11 23:59 (America/New_York)
The CRI IGNITE Award — Inspiring Growth and Nurturing Independence Through Excellence — supports the transition of outstanding postdoctoral researchers into independent tenure-track investigators. The program offers two sequential phases of funding:

Phase 1: Foundation Phase – Up to 2 years of postdoctoral support
Phase 2: Independence Phase – Up to 3 years of faculty support

IGNITE provides more than funding — it delivers a structured pathway to independence at a time when such opportunities are shrinking.
Phase 1: IGNITE Foundation Phase

Up to 2 years | $150,000 per year
Provides $90,000 a year in salary support, and $60,000 to fund independent work
Provides critical protected time, mentorship, and research support to help postdocs prepare for independence

Phase 2: IGNITE Independence Phase

Up to 3 years | $250,000 per year
Funding is contingent upon an adequate start-up package by the host institution

Supports early faculty as they launch new labs and pursue bold, high-impact research in cancer immunology.
Key Dates:
Application deadline: 11 January, 2027
SEE WEBSITE

Cancer Research Institute | Lloyd J. Old STAR Program
2027-01-15 23:59 (America/New_York)
The CRI Lloyd J. Old STAR Program — Scientists TAking Risks — provides long-term, flexible funding to mid-career scientists, giving them the freedom to pursue high-risk, high-reward research at the leading edge of cancer immunotherapy.
The ideal candidate is a bold, creative scientist who embraces risk in pursuit of breakthrough insights. They are distinguished by their ability to:

Leverage deep expertise and visionary curiosity to frame significant, non-obvious questions
Draw connections across disciplines to generate and test novel hypotheses
Pursue unconventional lines of inquiry, even at the risk of failure, with the potential for transformative success

Ultimately, CRI STARs will advance fundamental or translational discoveries that shape the development of immune-based therapies, broadening their impact for patients worldwide. CRI STARs not only drive innovation, they are defining the future of cancer immunology.
The Lloyd J. Old STAR Program provides $1.25M over a 5 year period. Institutions will be provided indirect costs of up to 10% of the total amount awarded. Indirects are provided in addition to awarded funds.
Key Dates:
Application deadline: 15 January, 2027
Invited interview: Spring 2027 (date TBD)
SEE WEBSITE

SMR International Congress
2027-03-07 - 2027-03-10 | Boston Marriott Copley Place, 110 Huntington Ave, Boston, MA, 02116, United States
More information will be available soon.
Location: Boston Marriott Copley Place, Boston, Massachusetts, USA
Key Dates:
Abstract Submission and Congress Registration Opens: 9 September 2026
Abstract Submission Deadline: 9 November 2026
Early Bird Registration Deadline: 22 December 2026
Regular Registration Deadline: 28 February 2027
Late Registration Deadline: 7 March 2027
FIND OUT MORE

USCAP 116th Annual Meeting
2027-03-13 - 2027-03-18 | Vancouver Convention Centre, 1055 Canada Pl, Vancouver, BC, V6C 0C3, Canada
More details coming soon.

Location: Vancouver Convention Centre, Vancouver, Canada
Key Dates:
Meeting dates: 13-18 March 2027

FIND OUT MORE

SSO Annual Meeting
2027-03-18 - 2027-03-20 | Walter E. Washington Convention Center, 801 Allen Y. Lew Place NW, Washington, D.C., 20001, United States
The #SSO2027 Annual Meeting will take place March 18-20, 2027, in Washington, DC. This year’s program will feature new educational sessions, disease site-specific content, dedicated programming for advanced practice providers, residents, and fellows, friendly competition, and expanded networking opportunities.
Location: Walter E. Washington Convention Center, Washington, DC
Key Dates:
Meeting dates: 18-20 March, 2027
Abstract submission deadline: 5 October, 2026
FIND OUT MORE

AAD Annual Meeting
2027-03-19 - 2027-03-23 | Moscone Center, 747 Howard Street, San Francisco, CA, 94103, United States
2027 AAD Annual Meeting is bridging dermatology education and community.
The 2027 AAD Annual Meeting heads to San Francisco and is your gateway to the highest standard of dermatology education, meaningful networking, and discovery. Bringing together comprehensive, practice-defining education across every area of the specialty to help you stay confident in your practice.
From world-class sessions to powerful peer connections, the 2027 AAD Annual Meeting is your destination for the most trusted education in dermatology. Stay tuned for more details and start planning your journey to the Bay.

Location: Moscone Center, San Francisco, California
Key Dates:
Meeting dates: 19-23 March 2027
Abstract submission deadline: 2 September 2026 at 11:59 a.m. CST

FIND OUT MORE

MRFF 2022 Frontier Health and Medical Research Grant
2027-03-31 17:00 (Australia/Sydney)
This grant program will support researchers to pursue big ideas to develop new products and interventions and implement these into clinical practice, benefiting patients, clinicians, and the health system.
This grant opportunity offers funding to support medical research and medical innovation programs of research (up to $25 million per program) that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition, through a series of linked projects. The program of research can propose to develop novel health technologies and/or re‑purpose existing health technologies in a novel way.
The initial application process to secure funding through this grant opportunity will be conducted in two stages:

expression of interest (EOI) – outlining a proposed program of research comprising of a series of linked projects with a 10-year time horizon
full application, (invitation only – following EOI) for a project of up to 5 years under the program of research.

Applicants may propose to commence research at any stage in the research pipeline from proof-of-concept, with the intention of achieving full implementation of the proposed technology in 10 years.
Funding for subsequent projects under the program of research that continue to progress the technology towards full implementation can be sought by submitting additional full applications to this grant opportunity (i.e. applicants do not need to recommence with an EOI). These applications may be submitted by invitation only.

Key Dates:
Expressions of Interest close: 31 March 2027
Last grants awarded by: 30 June 2028
SEE GRANT GUIDELINESSEE WEBSITE

NSW Cancer Summit 2027
2027-08-12 - 2027-08-13 | ICC Sydney and Cockle Bay – Darling Harbour, 14 Darling Dr, Sydney, NSW, 2000, Australia
The NSW Cancer Summit is coming back to the ICC Sydney on 12 and 13 August 2027, bringing together leading experts, researchers, clinicians, policymakers and advocates to help shape the future of cancer.
Showcasing NSW’s world-leading contributions to cancer research and innovation, the Summit will explore the latest advances across the cancer continuum, highlighting emerging discoveries, innovative approaches and opportunities to improve outcomes for people impacted by cancer.
Save the date! More details and event program to come.
Location: ICC Sydney

Key Dates: Thursday 12 and Friday 13 August 2027
FIND OUT MORE
